The phrase "achieving a safe and" is correct and usable in written English.
It can be used when discussing goals or objectives related to safety and security in various contexts, such as projects, policies, or practices.
Example: "Our primary focus is on achieving a safe and efficient work environment for all employees."
Alternatives: "attaining a secure and" or "ensuring a safe and".
CONCLUSION: The use of epidural analgesia, close monitoring and collaboration between the various disciplines were important in achieving a safe and uneventful labour in this high-risk parturient.
However, various socio-economic factors deter youths from receiving basic SRH information as well as achieving a safe and responsible sexual debut [ 3, 5, 8, 9].
Over the years, the in vitro culture of ADMSCs by platelet lysate (PL), a hemoderivate containing numerous growth factors and cytokines derived from platelet pools, has allowed achieving a safe and reproducible methodology to obtain high cell yield prior to clinical administration.
After the surgery, follow-up medical appointments are an important part of achieving a safe and significant long-term weight loss.
The result was that we achieved a safe and highly efficient mining operation of the C13 coal seam.
The study of such highly reactive systems is essential to achieve a safe and productive operation of existing processes and to ensure inherently safe new designs.
The sky crane system used for the Mars Science Laboratory by NASA can achieve a safe and precise landing, but it is highly complex.
Here we demonstrate that by using non-toxic fractions of saponin combined with CTA1-DD we can achieve a safe and above all highly efficacious mucosal adjuvant vector.
To achieve a safe and economic design it is necessary to investigate the mechanical response of structural components, connections and the overall system, thus leading to suitable design provisions.
He added: "The Isle of Wight is a wonderful part of the country, as is recognised not only by those who live there and move there to achieve a safe and rewarding quality of life for their families, but by the thousands of people who seek its benefits of tranquillity, beauty and many points of interest when holidaying there each year".
With the discontinued development of MAb 9F3, 13H5, ACO-1 and Rontalizumab100, two anti-IFN-α monoclonal antibodies (mAbs), Sifalimumab (MEDI-545) and AGS-009, have achieved a safe and dose-dependent reduction of the IFN-α signature in their clinical trials for SLE treatment101,102,103. Sifalimumab is a fully human mAb in phase II clinical trials for the treatment of SLE.
